威靈頓投資管理增持再鼎醫藥４４０萬股，涉資１﹒２億元

　　《經濟通通訊社２３日專訊》根據聯交所資料顯示，威靈頓投資管理於本周一（２１日）增
持再鼎醫藥（０９６８８）４４０萬股，每股平均價２７﹒２８０５元，涉資１﹒２億元，最新
持股量增至５﹒２４％。（ｂｉ）

送禮活動浪接浪！想緊貼著數活動消息？即Like etnet Facebook專頁！► 立即讚好

上一篇新聞︰25/07/2025 17:46 再鼎醫藥（０９６８８）－股權變動紀錄

下一篇新聞︰22/07/2025 10:58 《異動股》再鼎醫藥升逾一成突破２０天線，現報３０﹒１元

其他文章

04/08/2025 11:45 《異動股》康方生物跌近４％，美股下跌高估值創新藥股被拋售

01/08/2025 10:01 《異動股》康方升３％再破頂藥股個別升，特朗普要求境內藥品降價

30/07/2025 09:05 《盤前攻略》關稅寬限期未定中概受壓，恒指調整力未減續望兩萬五

03/07/2025 14:32 《異動股》創新藥續上揚康方飆近１４％，帶動生物科技指數升３％

03/07/2025 10:55 《異動股》康方再飆一成領漲創新藥，日前內地支持創新藥新政落地

備註：	即時報價更新時間為08/08/2025 17:59
	港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站

經濟通
強化版MQ
強化版TQ
財曆
Mobile
Web

客務熱線︰(852) 2880 7004 客務郵箱︰cs@etnet.com.hk
關於我們 | 產品服務 | 廣告查詢 | 聯絡我們 | 私隱政策 | 使用條款 | 網站導航 | 有用連結 | RSS新聞

Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.

《經濟通》所刊的署名及／或不署名文章，相關內容屬作者個人意見，並不代表《經濟通》立場，《經濟通》所扮演的角色是提供一個自由言論平台。